Net Loss Per Share (Tables)

3 Months Ended

Mar. 31, 2024

Earnings Per Share [Abstract]

Schedule of Antidilutive Securities

The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share

for the periods indicated because including them would have had an anti-dilutive effect (adjusted for after the Reverse Stock Split):

	Three Months Ended March 31,
	2024	2023
Public warrants	500,000	500,000
Private warrants	13,300	13,300
Stock options	336,270	336,563
Unvested restricted stock units	222,800	193,896
Warrants issued in connection with 15th amendment to Credit Agreement	—	80,000
Total common stock equivalents	1,072,370	1,123,759